Prelude Therapeutics To Participate in Two Upcoming
WILMINGTON, Del., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a
Globe Newswire9-02-2023, 21:11
ITS Logistics Funding the Supply Chain & Transportation 27-02-2023, 21:10